NZ504741A - Thermodynamically stable form of (R)-3-[ [(4-fluorophenyl) sulphonyl]amino] -1,2,3,4- tetrahydro -9H-carbazole -9-propanoic acid (ramatroban) - Google Patents

Thermodynamically stable form of (R)-3-[ [(4-fluorophenyl) sulphonyl]amino] -1,2,3,4- tetrahydro -9H-carbazole -9-propanoic acid (ramatroban)

Info

Publication number
NZ504741A
NZ504741A NZ504741A NZ50474198A NZ504741A NZ 504741 A NZ504741 A NZ 504741A NZ 504741 A NZ504741 A NZ 504741A NZ 50474198 A NZ50474198 A NZ 50474198A NZ 504741 A NZ504741 A NZ 504741A
Authority
NZ
New Zealand
Prior art keywords
thermodynamically stable
ramatroban
sulphonyl
carbazole
fluorophenyl
Prior art date
Application number
NZ504741A
Other languages
English (en)
Inventor
Alfons Grunenberg
Karl-Heinz Wahl
Klaus-Peter Voges
Original Assignee
Bayer Yakuhin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Yakuhin Ltd filed Critical Bayer Yakuhin Ltd
Publication of NZ504741A publication Critical patent/NZ504741A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
NZ504741A 1997-12-24 1998-12-24 Thermodynamically stable form of (R)-3-[ [(4-fluorophenyl) sulphonyl]amino] -1,2,3,4- tetrahydro -9H-carbazole -9-propanoic acid (ramatroban) NZ504741A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19757983A DE19757983A1 (de) 1997-12-24 1997-12-24 Thermodynamisch stabile Form von (r)-3[[(4-Fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-9H-carbazol-0-propansäure (Ramatroban)
PCT/JP1998/005844 WO1999033803A1 (en) 1997-12-24 1998-12-24 Thermodynamically stable form of (r)-3-[ [(4-fluorophenyl) sulphonyl]amino] -1,2,3,4- tetrahydro -9h-carbazole -9-propanoic acid (ramatroban)

Publications (1)

Publication Number Publication Date
NZ504741A true NZ504741A (en) 2002-10-25

Family

ID=7853457

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ504741A NZ504741A (en) 1997-12-24 1998-12-24 Thermodynamically stable form of (R)-3-[ [(4-fluorophenyl) sulphonyl]amino] -1,2,3,4- tetrahydro -9H-carbazole -9-propanoic acid (ramatroban)

Country Status (36)

Country Link
US (1) US6362214B1 (Direct)
EP (1) EP1051398B1 (Direct)
JP (2) JP3817668B2 (Direct)
KR (1) KR100586350B1 (Direct)
CN (1) CN1140510C (Direct)
AR (1) AR013803A1 (Direct)
AT (1) ATE263152T1 (Direct)
AU (1) AU744242B2 (Direct)
BG (1) BG65024B1 (Direct)
BR (1) BR9814496A (Direct)
CA (1) CA2313230A1 (Direct)
CO (1) CO4970800A1 (Direct)
DE (2) DE19757983A1 (Direct)
DK (1) DK1051398T3 (Direct)
ES (1) ES2218874T3 (Direct)
GT (1) GT199800198A (Direct)
HN (1) HN1998000186A (Direct)
HU (1) HUP0004432A3 (Direct)
ID (1) ID25446A (Direct)
IL (1) IL136278A (Direct)
IN (1) IN192932B (Direct)
MY (1) MY116312A (Direct)
NO (1) NO316618B1 (Direct)
NZ (1) NZ504741A (Direct)
PE (1) PE20000115A1 (Direct)
PL (1) PL341359A1 (Direct)
PT (1) PT1051398E (Direct)
RU (1) RU2220137C2 (Direct)
SI (1) SI1051398T1 (Direct)
SK (1) SK285109B6 (Direct)
TR (1) TR200001936T2 (Direct)
TW (1) TW552258B (Direct)
UA (1) UA66832C2 (Direct)
UY (2) UY25324A1 (Direct)
WO (1) WO1999033803A1 (Direct)
ZA (1) ZA9811817B (Direct)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2107907B1 (en) * 2006-12-20 2012-02-01 Cardoz AB Combination of pemirolast and ramatroban for use in the treatment of inflammatory disorders
AU2007344274A1 (en) * 2007-01-16 2008-07-24 Cardoz Ab New combination for use in the treatment of inflammatory disorders
WO2009007674A2 (en) * 2007-07-11 2009-01-15 Cardoz Ab Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and ramatroban or seratrodast
WO2011115069A1 (ja) * 2010-03-19 2011-09-22 第一三共株式会社 結晶の網羅的探索
CN103054857A (zh) * 2012-12-30 2013-04-24 北京阜康仁生物制药科技有限公司 一种以雷马曲班为活性成分的固体制剂
EP4420734A3 (en) 2015-02-13 2024-11-06 Institut National de la Santé et de la Recherche Médicale Ptgdr-1 and/or ptgdr-2 antagonists for preventing and/or treating systemic lupus erythematosus

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1557665A (en) * 1975-12-10 1979-12-12 Ici Ltd Process for the manufacture of a carboxyalkylamino anthraquinone compounds
US4616028A (en) * 1985-04-22 1986-10-07 American Home Products Corporation Substituted 2,3,4,9-tetrahydro-1H-carbazole-1-acetic acid derivatives, compositions and use
CN1015711B (zh) * 1986-02-21 1992-03-04 拜尔公司 制备环烷并[1，2-b]吲哚-磺酰胺类化合物的方法
DE3631824A1 (de) 1986-02-21 1988-03-31 Bayer Ag Cycloalkano(1.2-b)indol-sulfonamide
GB8924392D0 (en) * 1989-10-30 1989-12-20 Bayer Ag Substituted cycloalkano/b/dihydroindole-and-indolesulphonamides
DE19506739A1 (de) * 1995-02-27 1996-08-29 Bayer Ag [3-Amino]-tetrahydrocarbazol-propansäureester

Also Published As

Publication number Publication date
HUP0004432A3 (en) 2002-10-28
PL341359A1 (en) 2001-04-09
HN1998000186A (es) 1999-11-03
TW552258B (en) 2003-09-11
US6362214B1 (en) 2002-03-26
IL136278A0 (en) 2001-05-20
HUP0004432A2 (hu) 2001-06-28
NO316618B1 (no) 2004-03-08
ZA9811817B (en) 1999-06-29
BR9814496A (pt) 2000-10-10
MY116312A (en) 2003-12-31
CN1282320A (zh) 2001-01-31
JP2006151977A (ja) 2006-06-15
BG65024B1 (bg) 2006-12-29
AU744242B2 (en) 2002-02-21
HK1034517A1 (en) 2001-10-26
DE69822882D1 (en) 2004-05-06
KR20010033529A (ko) 2001-04-25
EP1051398B1 (en) 2004-03-31
CN1140510C (zh) 2004-03-03
TR200001936T2 (tr) 2001-01-22
JP2001527067A (ja) 2001-12-25
UY25324A1 (es) 2000-12-29
JP4411269B2 (ja) 2010-02-10
KR100586350B1 (ko) 2006-06-07
SK285109B6 (sk) 2006-06-01
ID25446A (id) 2000-10-05
AU1687499A (en) 1999-07-19
SI1051398T1 (en) 2004-08-31
BG104554A (en) 2001-05-31
NO20003217L (no) 2000-06-21
SK9752000A3 (en) 2001-02-12
UY25575A1 (es) 1999-11-17
CO4970800A1 (es) 2000-11-07
NO20003217D0 (no) 2000-06-21
RU2220137C2 (ru) 2003-12-27
GT199800198A (es) 1998-12-15
JP3817668B2 (ja) 2006-09-06
DK1051398T3 (da) 2004-07-19
IL136278A (en) 2005-03-20
DE19757983A1 (de) 1999-07-01
UA66832C2 (uk) 2004-06-15
WO1999033803A1 (en) 1999-07-08
DE69822882T2 (de) 2005-02-03
IN192932B (Direct) 2004-06-12
AR013803A1 (es) 2001-01-10
CA2313230A1 (en) 1999-07-08
ATE263152T1 (de) 2004-04-15
EP1051398A1 (en) 2000-11-15
PT1051398E (pt) 2004-07-30
ES2218874T3 (es) 2004-11-16
PE20000115A1 (es) 2000-03-26

Similar Documents

Publication Publication Date Title
AU616838B2 (en) N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro- 2h-benzopyran or dihydrobenzodioxin)carboxamide derivatives
IL129409A0 (en) 1-Phenylpyrazole compounds and pharmaceutical compositions containing the same
HU9302795D0 (en) Fungide compositions containing 2-(substituted phenyl)-ester of 3-metoxi-propenoic acid
NO20006221L (no) Fremgangsmåte for bekjempelse av skadedyr
NO996108L (no) 9-oksinerytromycinderivater
AU624405B2 (en) Heterocyclic bisphosphonic acid derivatives
PH25859A (en) Composition for treatment of ischemic disorder
MY132473A (en) Crystalline hydrochloride of (r)-(-)-2-<n-[4-(1,1- dioxido-3-oxo-2,3-dihydro-benzisothiazol-2-yl)-butyl]-aminomethyl>-chroman
CA2176935A1 (fr) Arylpiperazines derivees d'indole comme ligands pour les recepteurs 5 ht1-like 5 ht1b et 5 ht1d
EP0725074A3 (en) Intermediate compounds for the preparation of androst-3,5-diene-3-carboxy derivatives
ES8802420A1 (es) Un procedimiento para la preparacion de un derivado de acido 5-imidazolcarboxilico
AU1687199A (en) Nitrogen-containing heterocyclic compounds, their production and use
AU4834193A (en) Indole derivative, process for producing the same, and medicinal use thereof
RU95105435A (ru) N-замещенные производные 3-азабицикло [3.2.0]гептана в качестве нейролептического средства
ES8702427A1 (es) Un procedimiento para preparar derivados de 1,3-difosfonato
CA2219359A1 (en) Hydantoin derivatives as intermediates for pharmaceutical active compounds
IE802135L (en) Pyrazolobenzodiazepines
NZ504741A (en) Thermodynamically stable form of (R)-3-[ [(4-fluorophenyl) sulphonyl]amino] -1,2,3,4- tetrahydro -9H-carbazole -9-propanoic acid (ramatroban)
AU5784894A (en) Dihydrobenzofuran derivatives, their production and use
TW252979B (Direct)
CA2127374A1 (fr) Nouveau derive de l'isoindolinone, sa preparation et les compositions pharmaceutiques qui le contiennent
HRP950437A2 (en) N-substituted azabicycloheptane derivatives, their production and use
AU3217693A (en) Aminobenzoic acid derivatives
AU6599186A (en) N-(6-(4-0-hydrxyphenyl-1,3-dioxan-cis-5-yl)hexenoyl) suphonamide derivatives
HUT53103A (en) Process for the preparation of new 20,21-dinor-eburnamenine derivatives, new intermediates thereof, as well as pharmaceutical compositions containing said compounds as active ingredients

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)